Source BioScience is highlighting its hereditary cancer testing service, designed to help individuals and healthcare professionals better understand inherited cancer risk and make more informed decisions around screening, lifestyle and ongoing care.

Around 5–10% of cancers are associated with inherited genetic variants that can increase an individual’s risk of developing certain types of cancer. Identifying these variants can provide valuable information to support personalised approaches to managing that risk.

Hereditary cancer testing provides a comprehensive assessment of inherited risk, helping patients and their healthcare teams make informed decisions about appropriate next steps. Where indicated, this may include more frequent screening, which can support earlier detection should cancer develop.

Source BioScience’s hereditary cancer testing service aims to provide a straightforward route to comprehensive genetic analysis, with both blood and saliva collection options available. The service offers comprehensive as well as disease-specific panels, allowing testing to be tailored according to individual requirements.

Designed to support both patients and healthcare professionals, the service complements existing NHS pathways while helping to make hereditary cancer testing more accessible.

By improving access to genetic analysis, Source BioScience aims to give individuals greater insight into their inherited cancer risk and provide healthcare professionals with information that can help guide ongoing care and screening decisions.